OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Pancreatic Cancer cDNA Array I

Be the first to review this product
SKU
PNRT101
23 samples covering 4-normal, 2-Stage IB, 2-IIB, 2-III, 13-N/R. Available in 2, 5, 10 identical plates.
  $690.00
2 Weeks*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Pancreatic Cancer cDNA Array I
Clinical Info
Diagnosis Category Pancreatic Cancer
Tissue Pancreas
Shipping Ambient
Description 23 samples covering 4-normal, 2-Stage IB, 2-IIB, 2-III, 13-N/R. Available in 2, 5, 10 identical plates.
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
Kumari, Khan, Gupta et al
Oncogenesis (2018) 7 (2), 19 DOI: 10.1038/s41389-018-0031-0
AI Summary: OriGene’s PDAC tissue cDNA products were used to analyze and confirm the correlation between MUC13 and Glut-1 expression in pancreatic cancer patient samples in this study.
Snippet: 6a);and cDNA (N = 6) procured from Origene (Fig. 6b) b and cDNA from PDAC tissues (N = 6) procured from Origene. The correlation coefficient (r) and coefficient of determinations (r 2 ) were 0.982 and 0.862, respectively;
Inhibition of renalase expression and signaling has antitumor activity in pancreatic cancer
Guo, Hollander, MacPherson et al
Sci Rep (2016) 6, 22996 DOI: 10.1038/srep22996
Cited by 50
AI Summary: OriGene Technologies provided human cancer cDNA arrays (Screen cDNA Arrays I and II, pancreatic cancer cDNA array) that were used to analyze renalase expression in pancreatic cancer tissues in this study.
Snippet: Human cancer cDNA arrays (Screen cDNA Arrays I and II, pancreatic cancer cDNA array) were obtained from OriGene Technologies (Rockville, MD, USA). The relevant pathology reports are available online: http://www.origene.com/assets/documents/TissueScan. ... Cite SaveSaving
FigureFigureFigure
The CEA/CD3-bispecific antibody MEDI-565 (MT111) binds a nonlinear epitope in the full-length but not a short splice variant of CEA
Peng, Oberst, Huang et al
PLoS ONE (2012) 7 (5), e36412 DOI: 10.1371/journal.pone.0036412
Cited by 29
AI Summary: OriGene’s cancer tissue cDNA arrays (HCRT101, HGRT101, PNRT101, HLRT101, and BCRT101) were used in this study to analyze the expression of full-length and splice variant CEA transcripts across multiple tumor types.
Snippet: Cancer Tissue cDNA Arrays. Cancer tissue cDNA arrays: HCRT101 (Colon Cancer), HGRT101 (Gastroesophageal Cancer), PNRT101 (Pancreatic Cancer), HLRT101 (lung cancer), and BCRT101 (breast cancer) were purchased from OriGene Technologies (Rockville, MD).
FigureFigureFigure
Array
Showing 1-3 of 3 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products